Connect with us

Health

Cardiologist sheds light on making healthier choices in cooking oil

Published

on

On a beautiful Saturday morning, I find myself strolling down the aisle of the grocery store in my neighbourhood and as I approach the section dedicated to cooking oils, I am greeted by an array of options before me. The shelves are lined with bottles of various shapes and sizes, each boasting its own enticing combination of benefits.

With each bottle vying for my attention, I begin to scrutinise the labels, seeking out the perfect mix of taste and health. I weigh the benefits of different oils in my mind, considering their composition of fats and nutritional value.

As a journalist with over 10 years of reporting health-related topics, curiosity took the better part of me, as the quest for heart-healthy cooking has never been more prevalent. I will approach the story to provide valuable information to consumers about making healthier choices in cooking oil, with insights from a cardiologist guiding the narrative.

I reached out again to Dr Monisola Adanijo, a renowned cardiologist, who emphasised the significance of checking labels when purchasing cooking oil. “Consumers should pay close attention to the composition of fats in cooking oils. This can have a significant impact on heart health,” advises Dr. Adanijo.

According to her, one crucial aspect consumers should consider is the ratio of polyunsaturated fatty acids (PUFAs) to saturated fatty acids. PUFAs, such as omega-3 and omega-6 fatty acids, are beneficial for heart health. Therefore, consumers should look for oils with higher levels of PUFAs.

She notes that consumers should be wary of the saturated fat content listed on cooking oil labels, as excessive consumption of saturated fats can increase cholesterol levels and the risk of heart disease.

“Choosing oils with lower levels of saturated fats is advisable,” warns Dr. Adanijo

As I approached the end of the aisle, my gaze fell upon the label of Golden Terra Soya Oil—a standout option for health-conscious consumers. With an impressive content of 5 times more polyunsaturated fatty acids (PUFAs) compared to many other cooking oils, Golden Terra Soya Oil presents itself as a favourable choice for those prioritizing heart health in their culinary pursuit

With the assurance of both expert opinion and market trends, I felt confident in my decision to prioritise health without compromising on taste. Golden Terra Soya Oil not only met my culinary needs but also aligned with my commitment to a healthier lifestyle.

Golden Terra Soya Oil also boasts of three times less saturated fatty acids compared to traditional cooking oils. This makes it an ideal option for individuals seeking to reduce their saturated fat intake and ensure their cardiovascular well-being.

Chief Marketing Officer, TGI Group, Probal Bhattacharya, in his remark, gave a resounding affirmation of Golden Terra Oil’s alignment with evolving consumer preferences.

“As the landscape of consumer behaviour continues to shift towards prioritizing health and wellness, our commitment to providing cooking oils that not only excel in taste but also prioritise heart health, reflects our dedication to meeting the needs of our consumers.

“We strive to exceed the expectations of our consumers by offering products that resonate with their values and aspirations. As we continue to innovate and adapt to emerging trends, we remain committed to quality, health, and consumer satisfaction with products like Golden Terra Soya Oil,” he said.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Over 1,800 malnourished kids recovered in six months in Bauchi — CSOs

Published

on

Rauf Oyewole, Bauchi

The Coalition of Civil Society –Scaling Up Nutrition in Nigeria, Bauchi State Chapter has said that through its partnership with other implementing partners they have assisted over 1,800 malnourished children to recover from Severe Acute Malnutrition (SAM).

The Secretary of the Network, Dabis Mwalike while addressing journalists as part of the activities marking the 10th year anniversary of the network, said that it also engaged in preventive measures against malnutrition in the state.

According to her, during the implementation, 698 healthcare providers were trained across the 20 local government areas of Bauchi, 400 community-based volunteers were trained while 4,229 comprising 2,059 males and 2,170 females, children under five identified with SAM and 7,743 made of 3661males and 4082 females, children under five identified with Moderate Acute Malnutrition (MAM).

She added that 1,825 children under five identified with SAM and MAM recovered. While 202 PHCs established food banks.

She said that despite all the achievements, malnutrition remains a concern to public health and a threat to child survival, growth, and development in the country, and Bauchi State according to NNHS (2018) and NDHS (2018) the State stunting rate is 46 percent, wasting is 9.5 percent while underweight is 28.2 percent and overweight is 0.5 percent.

Continue Reading

Health

Capacity training will reduce migration of health workers- NPHCDA

Published

on

The National Primary Healthcare Development Agency (NPHCDA) says it is taking steps towards tackling migration of health workers through capacity training programmes.
Mr Julius Idoko, NPHCDA Coordinator in Cross River, said this at the opening of a five-day capacity training for 100 frontline healthcare workers in the state on Tuesday.
Idoko said that the training, a project of the Health Minister, Prof. Mohammad Pate, was aimed at improving the capacity of health workers and making migration out of the country less attractive.
”The rate at which health workers leave the country has become worrisome, this training is to build their capacities.
”This initiative is one of the steps we are taking to curb the continuous exodus of healthcare professionals from the country.
”If we continue to engage and improve the capacity of our health workers, there will be no reason for them to leave the country,” he said.
The cordinator said that the initiative targets to capture no fewer than 120,000 healthcare workers in public institutions across the country.
Also speaking, Dr Henry Ayuk, Cross River’s Commissioner for Health, described the training as ‘very important’ to the state following its peculiar challenges.
He said the training would strengthen the skills of healthcare workers and enhance their performances.
Ayuk said that the state government would equip no fewer then 450 primary health centres within the next one year to enhance healthcare delivery.
Dr Vivian Otu, Director-General, Cross Rivers Primary Healthcare Development Agency, commended NPHCDA for the initiative, describing it as timely and well-intended
He said thet those who benefited from the exercise would train others to ensure an active and efficient workforce.
The programme attracted participants from WHO, University of Calabar Teaching Hospital, President’s Malaria Initiative among others
Continue Reading

Health

WHO targets immunisation of one million people, as Nigeria becomes first country to receive new meningitis vaccine

Published

on

The World Health Organization (WHO) is targeting the immunisation of 1millikn persons as Nigeria becomes the first country in the world to roll out a new vaccine (Men5CV).

In a statement on Friday, WHO said that the vaccine would protect people against five strains of Meningococcus bacteria and described Nigeria’s feat as historic.

It said that health workers would begin an immunisation campaign aimed at reaching one million people.

The statement said that the vaccine and emergency vaccination activities are funded by Gavi, the Vaccine Alliance, which funds the global meningitis vaccine stockpile and supports lower-income countries with routine vaccination against meningitis.

According to the WHO, Nigeria is one of the 26 meningitis hyper-endemic countries in Africa, situated in the area known as the African Meningitis Belt.

It noted that in 2023, there was a 50 percent jump in annual meningitis cases reported across Africa.

“In Nigeria, an outbreak of Neisseria meningitidis (meningococcus) serogroup C outbreak, led to 1,742 suspected meningitis cases, including 101 confirmed cases and 153 deaths in seven of the 36 Nigerian states between October 2023 and March 2024.”

The states are Adamawa, Bauchi, Gombe, Jigawa, Katsina, Yobe, and Zamfara.

“To quell the deadly outbreak, a vaccination campaign was undertaken on March 25–28, 2024, to initially reach more than one million people aged 1-29 years,” it said.

The statement noted that meningitis is a serious infection that leads to the inflammation of the membranes (meninges) that surround and protect the brain and spinal cord.

“There are multiple causes of meningitis, including viral, bacterial, fungal, and parasitic pathogens.”

“Symptoms often include headache, fever, and stiff neck. Bacterial meningitis is the most serious and can also result in septicaemia (blood poisoning). It can seriously disable or kill within 24 hours,” the statement added.

It quoted WHO Director-General, Dr Tedros Ghebreyesus, as saying that meningitis was an old and deadly foe, adding that the new vaccine holds the potential to change the trajectory of the disease, preventing future outbreaks and saving many lives.

“Nigeria’s rollout brings us one step closer to our goal of eliminating meningitis by 2030,” Ghebreyesus said.

He said that the revolutionary new vaccine offers a powerful shield against the five major strains of the meningococcal bacteria – A, C, W, Y, and X – in a single shot.

All five strains cause meningitis and blood poisoning.

According to him, this provides broader protection than the current vaccine used in much of Africa, which is only effective against the A strain.

He said that the new vaccine has the potential to significantly reduce meningitis cases and advance progress in defeating meningitis.

“This is especially important for countries like Nigeria, where multiple serogroups are prevalent.

“The new vaccine uses the same technology as the meningitis A conjugate vaccine (MenAfriVac®), which wiped out meningococcal A epidemics in Nigeria,” the WHO boss said.

The statement quoted Prof. Muhammad Pate, Nigeria’s Minister of Health and Social Welfare, as saying that Northern Nigeria, particularly the states of Jigawa, Bauchi, and Yobe, were badly hit by the deadly outbreak of meningitis.

“This vaccine provides health workers with a new tool to both stop this outbreak and also put the country on a path to elimination,” Pate said.

According to him, Nigeria has done a lot of work preparing health workers and the health system for the rollout of the new vaccine.

“We got invaluable support from our populations in spite of the fasting period, and from our community leaders, especially the Emir of Gumel in Jigawa, who personally launched the vaccination campaign in the state.

“We’ll be monitoring progress closely and hopefully expand the immunisation in the coming months and years to accelerate progress,” he said.

The Minister said that the new multivalent conjugate vaccine took 13 years of effort and was based on a partnership between PATH and the Serum Institute of India.

“Financing from the UK government’s Foreign, Commonwealth, and Development Office was critical to its development,” he said.

Pate said that in July 2023, WHO prequalified the new Men5CV vaccine (which has brand name MenFive®), and in October 2023, it issued an official recommendation to countries to introduce the new vaccine.

According to him, Gavi allocated resources for the Men5CV rollout in December 2023, which are currently available for outbreak response through the emergency stockpile managed by the International Coordinating Group (ICG) on vaccine provision.

He added that the rollout, through mass preventive campaigns, was expected to start in 2025 across countries of the Meningitis Belt.

UK Minister for Development and Africa, Mr Andrew Mitchell, was also quoted as saying that the rollout of one million vaccines in northern Nigeria would help save lives, prevent long-term illness, and boost the goal of defeating meningitis globally by 2030.

“This is exactly the kind of scientific innovation supported by the UK, which I hope is replicated in years to come, to help us drive further breakthroughs, including wiping out other diseases,” Mitchell said.

He said that WHO has been supporting the Nigeria Centre for Disease Control and Prevention (NCDC) in responding to the meningitis outbreak in the country.

According to him, the areas of support include disease surveillance, active case finding, sample testing, and case management.

“WHO and partners have also played a vital role in supporting Nigeria to prepare for the rollout of the new vaccine and training health workers,” he said.

PATH’s Chief of Africa Region, Dr Nanthalile Mugala, was also quoted as saying that meningococcal meningitis had tormented countries across Africa year after year.

“The introduction of MenFive® in Nigeria heralds a transformative era in the fight against meningococcal meningitis in Africa.

“Building on the legacy of previous vaccination efforts, this milestone reflects over a decade of unwavering, innovative partnerships.

“The promise of MenFive® lies not just in its immediate impact but in the countless lives it stands to protect in the years to come, moving us closer to a future free from the threat of this disease,” Mugala said.

According to her, in 2019, WHO and partners launched the global roadmap to defeating meningitis by 2030.

“The roadmap sets a comprehensive vision towards a world free of meningitis and has three goals, including the elimination of bacterial meningitis epidemics.

Another goal is the reduction of cases of vaccine-preventable bacterial meningitis by 50 percent and deaths by 70 percent, as well as the reduction of disability and improvement of quality of life after meningitis, due to any cause.

Chief Programme Officer at Gavi, the Vaccine Alliance, Ms Aurélia Nguyen, was also quoted as saying that with outbreaks of infectious diseases on the rise worldwide, new innovations such as MenFive® were critical in helping the fight back.

She said that Vaccine Alliance funds the global stockpile as well as vaccine rollout in lower-income countries.

“This first shipment signals the start of Gavi support for a multivalent meningococcal conjugate vaccine (MMCV) programme which, with the required donor funding for our next five years of work, will see pentavalent meningococcal conjugate vaccines rolled out in high-risk countries.

“Thanks to vaccines, we have eliminated large and disruptive outbreaks of meningitis A in Africa, and now we have a tool to respond to other serogroups that still cause large outbreaks, resulting in long-term disability and deaths,” Nguyen said.

According to her, following Nigeria’s meningitis vaccine campaign, a major milestone on the road to defeat meningitis is the international summit on meningitis taking place in Paris in April 2024, where leaders will celebrate progress, identify challenges and assess next steps.

“It is also an opportunity for country leaders and key partners to commit, politically and financially, to accelerate progress towards eliminating meningitis as a public health problem by 2030,” she said.

Continue Reading

Trending